Company intelligence / Profile preview

Qingdao Honghongyuan Health Industry Technology

Qingdao, Shandong, China

Ownership: Private
Development stage: Other

Overview

Company operates a manufacturing facility (formerly Runde, now indirectly managed by Xiaogang), producing steviol glycosides and glycosylated steviol glycosides under contract for GLG Life Tech and for domestic sales in China. No drug development or clinical pipeline.

Industry: Food & Nutrition

Partnerships

GLG Life Tech Corporation (long-term exclusive contract manufacturing and operational partnership for steviol glycoside production)

Beyond the preview

Go deeper on Qingdao Honghongyuan Health Industry Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingdao Honghongyuan Health Industry Technology.

Explore the full profile